Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Prospective analysis of bleeding events in left ventricular assist device patients.

Sherazi S, Kouides P, Francis C, Lowenstein CJ, Refaai M, Conley G, Johnson BA, Muchnik E, Lien S, Massey HT, Alexis JD.

Int J Artif Organs. 2018 May;41(5):269-276. doi: 10.1177/0391398818762353. Epub 2018 Mar 22.

PMID:
29562808
2.

Platelet glycoprotein Ibα ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices.

Hu J, Mondal NK, Sorensen EN, Cai L, Fang HB, Griffith BP, Wu ZJ.

J Heart Lung Transplant. 2014 Jan;33(1):71-9. doi: 10.1016/j.healun.2013.08.013. Epub 2013 Sep 19.

3.

Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.

Meyer AL, Malehsa D, Budde U, Bara C, Haverich A, Strueber M.

JACC Heart Fail. 2014 Apr;2(2):141-5. doi: 10.1016/j.jchf.2013.10.008.

4.

Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.

Meyer AL, Malehsa D, Bara C, Budde U, Slaughter MS, Haverich A, Strueber M.

Circ Heart Fail. 2010 Nov;3(6):675-81. doi: 10.1161/CIRCHEARTFAILURE.109.877597. Epub 2010 Aug 25.

PMID:
20739614
5.

Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients.

Crow S, Chen D, Milano C, Thomas W, Joyce L, Piacentino V 3rd, Sharma R, Wu J, Arepally G, Bowles D, Rogers J, Villamizar-Ortiz N.

Ann Thorac Surg. 2010 Oct;90(4):1263-9; discussion 1269. doi: 10.1016/j.athoracsur.2010.04.099.

PMID:
20868825
6.

Comparative analysis of von Willebrand factor profiles after implantation of left ventricular assist device and total artificial heart.

Reich HJ, Morgan J, Arabia F, Czer L, Moriguchi J, Ramzy D, Esmailian F, Lam L, Dunhill J, Volod O.

J Thromb Haemost. 2017 Aug;15(8):1620-1624. doi: 10.1111/jth.13753. Epub 2017 Jul 5.

PMID:
28586149
7.

Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump.

Goda M, Jacobs S, Rega F, Peerlinck K, Jacquemin M, Droogne W, Vanhaecke J, Van Cleemput J, Van den Bossche K, Meyns B.

J Heart Lung Transplant. 2013 May;32(5):539-45. doi: 10.1016/j.healun.2013.02.006.

PMID:
23570742
8.

Pilot investigation of a novel testing strategy for bleeding in ventricular assist device recipients.

Joyce D, Crow S, Li Z, Joyce L, Milano C, Rogers J, Villamizar-Ortiz N, Chen D.

J Heart Lung Transplant. 2012 Jul;31(7):750-6. doi: 10.1016/j.healun.2012.02.032. Epub 2012 Apr 25.

PMID:
22538169
9.

Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.

Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat PV, Cappleman S, Naka Y, Mancini D.

J Am Coll Cardiol. 2010 Oct 5;56(15):1207-13. doi: 10.1016/j.jacc.2010.05.016. Epub 2010 Jul 2.

10.

Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.

Geisen U, Heilmann C, Beyersdorf F, Benk C, Berchtold-Herz M, Schlensak C, Budde U, Zieger B.

Eur J Cardiothorac Surg. 2008 Apr;33(4):679-84. doi: 10.1016/j.ejcts.2007.12.047. Epub 2008 Feb 20.

PMID:
18282712
11.

Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.

Kang J, Zhang DM, Restle DJ, Kallel F, Acker MA, Atluri P, Bartoli CR.

J Thorac Cardiovasc Surg. 2016 Jun;151(6):1747-1754.e1. doi: 10.1016/j.jtcvs.2016.01.031. Epub 2016 Jan 30.

12.

Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.

Bartoli CR, Kang J, Restle DJ, Zhang DM, Shabahang C, Acker MA, Atluri P.

JACC Heart Fail. 2015 Nov;3(11):860-9. doi: 10.1016/j.jchf.2015.06.016. Epub 2015 Oct 7.

13.

Platelet dysfunction and acquired von Willebrand syndrome in patients with left ventricular assist devices.

Baghai M, Heilmann C, Beyersdorf F, Nakamura L, Geisen U, Olschewski M, Zieger B.

Eur J Cardiothorac Surg. 2015 Sep;48(3):421-7. doi: 10.1093/ejcts/ezu510. Epub 2014 Dec 27.

PMID:
25543177
14.

Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center.

Esmaeilzadeh F, Wauters A, Wijns W, Argacha JF, van de Borne P.

BMC Cardiovasc Disord. 2016 Aug 2;16(1):155. doi: 10.1186/s12872-016-0334-z.

15.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
16.

Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure.

Netuka I, Kvasnička T, Kvasnička J, Hrachovinová I, Ivák P, Mareček F, Bílková J, Malíková I, Jančová M, Malý J, Sood P, Sundareswaran KS, Connors JM, Mehra MR.

J Heart Lung Transplant. 2016 Jul;35(7):860-7. doi: 10.1016/j.healun.2016.05.019. Epub 2016 May 31.

PMID:
27435529
17.

Pulmonary Bleeding During Right Ventricular Support After Left Ventricular Assist Device Implantation.

Welp H, Sindermann JR, Deschka H, Martens S, Scherer M.

J Cardiothorac Vasc Anesth. 2016 Jun;30(3):627-31. doi: 10.1053/j.jvca.2015.07.012. Epub 2015 Jul 14.

PMID:
26460277
18.

Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients.

Crow S, Milano C, Joyce L, Chen D, Arepally G, Bowles D, Thomas W, Ortiz NV.

ASAIO J. 2010 Sep-Oct;56(5):441-5. doi: 10.1097/MAT.0b013e3181e5de0a.

PMID:
20613494
19.

Intraplatelet reactive oxygen species, mitochondrial damage and platelet apoptosis augment non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist device.

Mondal NK, Sorensen EN, Hiivala NJ, Feller ED, Pham SM, Griffith BP, Wu ZJ.

Platelets. 2015;26(6):536-44. doi: 10.3109/09537104.2014.948840. Epub 2014 Aug 28.

PMID:
25167344
20.

Use of left ventricular assist device (HeartMate II): a Singapore experience.

Lim CP, Sivathasan C, Tan TE, Lim CH, Kerk KL, Sim DK.

Artif Organs. 2014 Jul;38(7):543-8. doi: 10.1111/aor.12247. Epub 2014 Jan 7.

PMID:
24392937

Supplemental Content

Support Center